GLUCARPIDASE

GLUCARPIDASE was reported 363 times

These side effects are most commonly reported by patients taking GLUCARPIDASE:

# Side effect Count
0 OFF LABEL USE 92
1 UNDERDOSE 62
2 LABORATORY TEST INTERFERENCE 58
3 ACUTE KIDNEY INJURY 36
4 BLOOD CREATININE INCREASED 34
5 TOXICITY TO VARIOUS AGENTS 34
6 DRUG EFFECT INCOMPLETE 33
7 REBOUND EFFECT 33
8 DRUG INEFFECTIVE 31
9 DEATH 27
10 RENAL FAILURE 25
11 MUCOSAL INFLAMMATION 23
12 DRUG LEVEL INCREASED 16
13 ALANINE AMINOTRANSFERASE INCREASED 15
14 FALSE POSITIVE INVESTIGATION RESULT 15
15 PANCYTOPENIA 15
16 NO ADVERSE EVENT 14
17 PRODUCT USE IN UNAPPROVED INDICATION 14
18 TOXIC EPIDERMAL NECROLYSIS 14
19 NEPHROPATHY TOXIC 13
20 RENAL IMPAIRMENT 13
21 ASPARTATE AMINOTRANSFERASE INCREASED 11
22 HYPERVOLAEMIA 11
23 NEUTROPENIA 11
24 DRUG CLEARANCE DECREASED 9
25 DRUG INTERACTION 9
26 RENAL FAILURE ACUTE 9
27 ENCEPHALOPATHY 8
28 THROMBOCYTOPENIA 8
29 CONDITION AGGRAVATED 7
30 DISEASE PROGRESSION 7
31 FLUID OVERLOAD 7
32 PLEURAL EFFUSION 7
33 BLOOD BILIRUBIN INCREASED 6
34 CONTRAINDICATED PRODUCT ADMINISTERED 6
35 PRESCRIBED UNDERDOSE 6
36 ABDOMINAL PAIN 5
37 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5
38 FLUID RETENTION 5
39 HYPOTENSION 5
40 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5
41 OVERDOSE 5
42 ANAEMIA 4
43 BONE MARROW FAILURE 4
44 DYSPNOEA 4
45 GASTROINTESTINAL HAEMORRHAGE 4
46 HAEMODIALYSIS 4
47 HEPATOCELLULAR INJURY 4
48 HYPERTRANSAMINASAEMIA 4
49 HYPOXIA 4
50 INCORRECT DOSE ADMINISTERED 4
51 INTERNATIONAL NORMALISED RATIO INCREASED 4
52 NEUROTOXICITY 4
53 OEDEMA 4
54 PNEUMONIA 4
55 SEIZURE 4
56 SEPSIS 4
57 SEPTIC SHOCK 4
58 THERAPY CHANGE 4
59 AGITATION 3
60 ANURIA 3
61 AZOTAEMIA 3
62 CONFUSIONAL STATE 3
63 CRYSTAL NEPHROPATHY 3
64 DRUG EFFECT DECREASED 3
65 DYSARTHRIA 3
66 HYPERKALAEMIA 3
67 HYPERTENSION 3
68 INTENTIONAL PRODUCT USE ISSUE 3
69 LIVER DISORDER 3
70 MENTAL STATUS CHANGES 3
71 METABOLIC ACIDOSIS 3
72 NON-HODGKIN^S LYMPHOMA 3
73 PRODUCT AVAILABILITY ISSUE 3
74 PULMONARY OEDEMA 3
75 PYREXIA 3
76 RASH ERYTHEMATOUS 3
77 RESPIRATORY FAILURE 3
78 STAPHYLOCOCCAL BACTERAEMIA 3
79 STAPHYLOCOCCAL INFECTION 3
80 SUBDURAL HAEMATOMA 3
81 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
82 THERAPEUTIC RESPONSE DECREASED 3
83 THERAPY PARTIAL RESPONDER 3
84 VOMITING 3
85 ACIDOSIS 2
86 ALKALOSIS 2
87 ANAPHYLACTIC REACTION 2
88 ASCITES 2
89 BILIRUBIN CONJUGATED INCREASED 2
90 BLOOD ALKALINE PHOSPHATASE INCREASED 2
91 BRAIN OEDEMA 2
92 CARDIOGENIC SHOCK 2
93 CEREBRAL HAEMORRHAGE 2
94 CEREBROVASCULAR ACCIDENT 2
95 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 2
96 CLOSTRIDIUM DIFFICILE COLITIS 2
97 CONTINUOUS HAEMODIAFILTRATION 2
98 CRYSTALLURIA 2
99 DIALYSIS 2
100 DRUG ERUPTION 2
101 DRUG-INDUCED LIVER INJURY 2
102 DYSPHAGIA 2
103 EPIDERMAL NECROSIS 2
104 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
105 GLOMERULAR FILTRATION RATE DECREASED 2
106 HEPATIC FAILURE 2
107 HEPATIC FUNCTION ABNORMAL 2
108 HEPATOTOXICITY 2
109 HOSPITALISATION 2
110 HYPERSENSITIVITY 2
111 INTENTIONAL UNDERDOSE 2
112 LIVER INJURY 2
113 LOSS OF CONSCIOUSNESS 2
114 MALAISE 2
115 MALIGNANT NEOPLASM PROGRESSION 2
116 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2
117 MYELOSUPPRESSION 2
118 NO THERAPEUTIC RESPONSE 2
119 PRESCRIBED OVERDOSE 2
120 PRODUCT QUALITY ISSUE 2
121 RASH VESICULAR 2
122 RENAL PAIN 2
123 RESPIRATORY ARREST 2
124 RESPIRATORY DISTRESS 2
125 STATUS EPILEPTICUS 2
126 THERAPEUTIC PRODUCT EFFECT DECREASED 2
127 TOXIC ENCEPHALOPATHY 2
128 TOXIC SKIN ERUPTION 2
129 TREATMENT DELAYED 2
130 UNRESPONSIVE TO STIMULI 2
131 URINE OUTPUT DECREASED 2
132 WEIGHT INCREASED 2
133 ACUTE RESPIRATORY DISTRESS SYNDROME 1
134 AGGRESSION 1
135 ALANINE AMINOTRANSFERASE ABNORMAL 1
136 ALTERED STATE OF CONSCIOUSNESS 1
137 AMNESIA 1
138 ARACHNOIDITIS 1
139 ARRHYTHMIA 1
140 ASPARTATE AMINOTRANSFERASE ABNORMAL 1
141 ASTERIXIS 1
142 ATAXIA 1
143 ATRIAL FIBRILLATION 1
144 BACTERAEMIA 1
145 BACTERIAL SEPSIS 1
146 BEDRIDDEN 1
147 BLOOD ALBUMIN DECREASED 1
148 BLOOD CHOLESTEROL ABNORMAL 1
149 BLOOD COUNT ABNORMAL 1
150 BLOOD CULTURE POSITIVE 1
151 BLOOD ELECTROLYTES ABNORMAL 1
152 BLOOD TRIGLYCERIDES ABNORMAL 1
153 BLOOD UREA INCREASED 1
154 CARDIAC ARREST 1
155 CARDIAC FAILURE 1
156 CARDIO-RESPIRATORY ARREST 1
157 CARDIORENAL SYNDROME 1
158 CEREBROSPINAL FLUID LEAKAGE 1
159 CLOSTRIDIUM DIFFICILE INFECTION 1
160 CORONARY ARTERY DISEASE 1
161 COUGH 1
162 CYTOPENIA 1
163 DEEP VEIN THROMBOSIS 1
164 DEMENTIA 1
165 DERMATITIS 1
166 DIABETES MELLITUS 1
167 DRUG EFFECT DELAYED 1
168 DRUG HYPERSENSITIVITY 1
169 DRUG LEVEL DECREASED 1
170 DRUG LEVEL FLUCTUATING 1
171 ELECTROLYTE IMBALANCE 1
172 EROSIVE OESOPHAGITIS 1
173 EXTRA DOSE ADMINISTERED 1
174 FATIGUE 1
175 FEBRILE NEUTROPENIA 1
176 FRONTOTEMPORAL DEMENTIA 1
177 GAIT DISTURBANCE 1
178 GENERAL PHYSICAL HEALTH DETERIORATION 1
179 GENERALISED OEDEMA 1
180 GENERALISED TONIC-CLONIC SEIZURE 1
181 GENITAL EROSION 1
182 HAEMODYNAMIC INSTABILITY 1
183 HEADACHE 1
184 HEPATIC STEATOSIS 1
185 HEPATOMEGALY 1
186 HEPATORENAL SYNDROME 1
187 HERPES ZOSTER 1
188 HYPOKALAEMIA 1
189 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
190 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
191 INFUSION RELATED REACTION 1
192 INFUSION SITE REACTION 1
193 INJECTION SITE INFECTION 1
194 INTENTIONAL PRODUCT MISUSE 1
195 LEUKAEMIC LYMPHOMA 1
196 LOWER RESPIRATORY TRACT INFECTION 1
197 MEDICATION ERROR 1
198 NAUSEA 1
199 NECK PAIN 1
200 NEUROLOGICAL DECOMPENSATION 1
201 NEUTROPHIL COUNT DECREASED 1
202 NEUTROPHIL COUNT INCREASED 1
203 OEDEMA PERIPHERAL 1
204 OLIGURIA 1
205 ORAL MUCOSA EROSION 1
206 OSTEONECROSIS OF JAW 1
207 OSTEOSARCOMA METASTATIC 1
208 OSTEOSARCOMA RECURRENT 1
209 OXYGEN SATURATION DECREASED 1
210 PERICARDIAL EFFUSION 1
211 PNEUMOCYSTIS JIROVECII PNEUMONIA 1
212 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1
213 PRODUCT ADMINISTRATION ERROR 1
214 PRODUCT PRESCRIBING ERROR 1
215 PRODUCT SUPPLY ISSUE 1
216 PROTHROMBIN LEVEL DECREASED 1
217 PROTHROMBIN TIME PROLONGED 1
218 PSYCHOTIC DISORDER 1
219 PULMONARY EMBOLISM 1
220 PULSE ABSENT 1
221 RADIOTHERAPY 1
222 RASH 1
223 RECTAL HAEMORRHAGE 1
224 RENAL DISORDER 1
225 RENAL TUBULAR NECROSIS 1
226 RESPIRATORY DEPRESSION 1
227 RESUSCITATION 1
228 SKIN EXFOLIATION 1
229 SKIN INFECTION 1
230 SKIN LESION 1
231 SYSTEMIC CANDIDA 1
232 TACHYCARDIA 1
233 THERAPEUTIC RESPONSE UNEXPECTED 1
234 THROMBOSIS 1
235 TOXIC LEUKOENCEPHALOPATHY 1
236 TRANSAMINASES INCREASED 1
237 URINARY RETENTION 1
238 URINARY TRACT INFECTION 1
239 URINE OUTPUT 1
240 VENTRICULAR TACHYCARDIA 1
241 WALKING AID USER 1
242 WHITE BLOOD CELL COUNT INCREASED 1